Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)Tiziano Barbui, Ayalew Tefferi, Guido Finazzi et al.|Blood|2012Cited by 596
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International StudyTiziano Barbui, Ayalew Tefferi, Heinz Gisslinger et al.|Journal of Clinical Oncology|2011Cited by 540
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patientsAlessandra Carobbio, Tiziano Barbui, Jüergen Thiele et al.|Blood|2011Cited by 448
Practice-relevant revision of IPSET-thrombosis based on 1019 patients with WHO-defined essential thrombocythemiaTiziano Barbui, Ayalew Tefferi, Alessandro M. Vannucchi et al.|Blood Cancer Journal|2015Cited by 273
A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and TreatmentFrancesco Passamonti, Ayalew Tefferi, Jürgen Thiele et al.|Blood|2012Cited by 270